HeartBeam, Inc.

NasdaqCM BEAT

HeartBeam, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2024

HeartBeam, Inc. Debt to Equity Ratio is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

NasdaqCM: BEAT

HeartBeam, Inc.

CEO	Mr. Robert P. Eno
IPO Date	Nov. 11, 2021
Location	United States
Headquarters	2118 Walsh Avenue
Employees	15
Sector	Healthcare
Industries Telehealth Medical Instruments

Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Key trends

Past 5 years